Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Medicare Rx Premium Of $35 Would Keep Two-Thirds Of Seniors Out – AARP

  • News

Executive Summary

A Medicare drug benefit premium of $35 a month would keep two-thirds of eligible beneficiaries from enrolling in the program, AARP told a Senate Finance Committee hearing March 7

You may also be interested in...



HIAA Warns Against “Drug-Only” Rx Benefit Ahead Of Thomas Medicare Bill

HIAA is pushing for a Medicare drug benefit that is integrated into the full package of services in advance of the introduction of Rep. Bill Thomas' (R-Calif.) Rx benefit bill

HIAA Warns Against “Drug-Only” Rx Benefit Ahead Of Thomas Medicare Bill

HIAA is pushing for a Medicare drug benefit that is integrated into the full package of services in advance of the introduction of Rep. Bill Thomas' (R-Calif.) Rx benefit bill

Medicare Rx Premium Acceptance Polls Do Not Reflect “Reality” – Thomas

Concerns that high premiums will discourage seniors from enrolling in a Medicare drug program will not be borne out when seniors are actually presented with a viable drug benefit, House Ways & Means Committee Chairman Bill Thomas (R-Calif.) declared

Table

View full table

Related Content

Pink Sheet
Tags:
Latest Headlines

Gene Therapy: Pediatric Development Could Start Sooner Than Sponsors Think – FDA OTP Director

Puberty Blockers: FDA's Califf Asked If REMS, Boxed Warning Against Off-Label Use In The Works

ADHD Drugs: FDA Commissioner Blames Inappropriate Prescribing For Shortages

Moment Of Truth For Seven EU Filings; Cytokinetics To Make Its Case For Heart Failure Drug

See All
UsernamePublicRestriction

Register

PS039449

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By